You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the POLYSORBATE 20 Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) POLYSORBATE 20


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POLYSORBATE 20 excipient, and estimated key patent expiration / generic entry dates

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Alcon Laboratories Inc CIPRO ciprofloxacin hydrochloride and hydrocortisone 0065-8531 POLYSORBATE 20
Haleon US Holdings LLC EXCEDRIN acetaminophen, asprin, caffeine 0067-2035 POLYSORBATE 20
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 POLYSORBATE 20
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin, and caffeine 0067-2040 POLYSORBATE 20
Novartis Pharmaceuticals Corporation MAXITROL neomycin sulfate, polymyxin b sulfate and dexamethasone 0078-0792 POLYSORBATE 20
Novartis Pharmaceuticals Corporation CIPRO ciprofloxacin hydrochloride and hydrocortisone 0078-0855 POLYSORBATE 20
Bausch Health US LLC TARGRETIN bexarotene 0187-5526 POLYSORBATE 20
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Generic drugs containing POLYSORBATE 20 excipient

Company Ingredient NDC Excipient
Eli Lilly and Company lebrikizumab-lbkz 0002-7772 POLYSORBATE 20
Eli Lilly and Company olaratumab 0002-8926 POLYSORBATE 20
Merck Sharp & Dohme LLC pneumococcal 15-valent conjugate vaccine crm197 protein adsorbed 0006-4329 POLYSORBATE 20
Merck Sharp & Dohme LLC pneumococcal 21-valent conjugate vaccine 0006-4347 POLYSORBATE 20
Merck Sharp & Dohme Corp adalimumab-bwwd 0006-5031 POLYSORBATE 20
Merck Sharp & Dohme Corp trastuzumab 0006-5033 POLYSORBATE 20
sanofi-aventis US LLC ziv-aflibercept 0024-5840 POLYSORBATE 20
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group